Medtech InsightThe US Federal Trade Commission has requested a second round of documents in its review of a proposed merger between aesthetics company Allergan, Inc. and device manufacturer Soliton, Inc. , raisin
ScripScrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. AstraZeneca To Study ‘Elite Controller’